Cargando…
Ineffectiveness of tumor necrosis factor-α blockers and ustekinumab in a case of type IV pityriasis rubra pilaris
Treatment of pityriasis rubra pilaris (PRP) may be difficult since no standardized therapeutic approach has been established. Recently, tumor necrosis factor-α (TNF-α) blockers have been demonstrated to be favorable in the management of recalcitrant PRP. The authors report a case of a patient who pr...
Autores principales: | Lernia, Vito Di, Ficarelli, Elena, Zanelli, Magda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439754/ https://www.ncbi.nlm.nih.gov/pubmed/26009720 http://dx.doi.org/10.4103/2229-5178.156410 |
Ejemplares similares
-
Ustekinumab as an Alternative Treatment Option for Chronic Pityriasis Rubra Pilaris
por: Chowdhary, Mudit, et al.
Publicado: (2015) -
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin
por: Katharina, Medek, et al.
Publicado: (2022) -
Photosensitive pityriasis rubra pilaris
por: Męcińska-Jundziłł, Kaja, et al.
Publicado: (2016) -
Juvenile Pityriasis Rubra Pilaris
por: Xie, Yihang, et al.
Publicado: (2023) -
Two Cases of Pityriasis Rubra Pilaris
por: Pai, M. N.
Publicado: (1933)